Literature DB >> 25186615

The role of surgical debridement in different clinical manifestations of invasive aspergillosis.

Frederike Reischies1, Martin Hoenigl.   

Abstract

Invasive aspergillosis (IA) has a wide spectrum of clinical presentations and is associated with high mortality rates. Early initiation of systemic antimould therapy remains the most important measure to reduce mortality. Surgical debridement is an important additional therapeutic option mainly in cases of extrapulmonary IA. The main intention for surgical intervention in IA is to obtain material for diagnosis and antifungal susceptibility testing. There are, however, also therapeutic implications for surgical interventions in rare manifestation of IA such as endocarditis or mycotic aneurysm. Here, we will review the role of surgical interventions in the treatment of different clinical manifestations of IA.
© 2014 Blackwell Verlag GmbH.

Entities:  

Keywords:  CNS; aspergillus; endocarditis; osteomyelitis; pleuritis; surgery

Mesh:

Substances:

Year:  2014        PMID: 25186615     DOI: 10.1111/myc.12224

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  11 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

Review 2.  Aspergillus fumigatus and Aspergillosis in 2019.

Authors:  Jean-Paul Latgé; Georgios Chamilos
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

3.  How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions.

Authors:  Ana Fernández-Cruz; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

Review 4.  [Aspergillus in airway material : Ignore or treat?]

Authors:  H J F Salzer; C Lange; M Hönigl
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

Review 5.  Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status.

Authors:  Sven Heldt; Martin Hoenigl
Journal:  Curr Fungal Infect Rep       Date:  2017-04-29

Review 6.  Treatment of Aspergillosis.

Authors:  Jeffrey D Jenks; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2018-08-19

Review 7.  Factors affecting patient outcome in primary cutaneous aspergillosis.

Authors:  Alexander M Tatara; Antonios G Mikos; Dimitrios P Kontoyiannis
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 8.  Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.

Authors:  Jeffrey D Jenks; Helmut Jf Salzer; Juergen Prattes; Robert Krause; Dieter Buchheidt; Martin Hoenigl
Journal:  Drug Des Devel Ther       Date:  2018-04-30       Impact factor: 4.162

9.  Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings.

Authors:  David W Denning; Iain D Page; Jeremiah Chakaya; Kauser Jabeen; Cecilia M Jude; Muriel Cornet; Ana Alastruey-Izquierdo; Felix Bongomin; Paul Bowyer; Arunaloke Chakrabarti; Sara Gago; John Guto; Bruno Hochhegger; Martin Hoenigl; Muhammad Irfan; Nicholas Irurhe; Koichi Izumikawa; Bruce Kirenga; Veronica Manduku; Samihah Moazam; Rita O Oladele; Malcolm D Richardson; Juan Luis Rodriguez Tudela; Anna Rozaliyani; Helmut J F Salzer; Richard Sawyer; Nasilele F Simukulwa; Alena Skrahina; Charlotte Sriruttan; Findra Setianingrum; Bayu A P Wilopo; Donald C Cole; Haileyesus Getahun
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

10.  Delayed Diagnosis of a Diffuse Invasive Gastrointestinal Aspergillosis in an Immunocompetent Patient.

Authors:  S Guglielmetti; C M Jaccard; K Mühlethaler; A Bigler; D Springe; L Ebnöther; M Delgado
Journal:  Case Rep Crit Care       Date:  2020-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.